WallStreetZenWallStreetZen

NASDAQ: ONVO
Organovo Holdings Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ONVO stock forecasts and price targets.

Forecast return on equity

Is ONVO forecast to generate an efficient return?

Forecast return on assets

Is ONVO forecast to generate an efficient return on assets?

ONVO revenue forecast

What is ONVO's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$440.0k+81.82%
Avg 2 year Forecast
$530.0k+119.01%
ONVO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ONVO revenue growth forecast

How is ONVO forecast to perform vs Biotechnology companies and vs the US market?
Company
47.99%
Industry
60.26%
Market
9.39%
ONVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ONVO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ONVO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ONVO$1.15N/AN/A
HEPA$2.11N/AN/A
ERNA$2.15N/AN/A
BNOX$0.98$8.00+716.33%Buy
MNPR$0.68$2.00+194.99%Strong Buy

Organovo Holdings Stock Forecast FAQ

What is ONVO's revenue growth forecast for 2025-2026?

(NASDAQ: ONVO) Organovo Holdings's forecast annual revenue growth rate of 47.99% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 60.26%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.39%.

Organovo Holdings's revenue in 2024 is $242,000.On average, 1 Wall Street analysts forecast ONVO's revenue for 2025 to be $4,417,633, with the lowest ONVO revenue forecast at $4,417,633, and the highest ONVO revenue forecast at $4,417,633.

In 2026, ONVO is forecast to generate $5,321,239 in revenue, with the lowest revenue forecast at $5,321,239 and the highest revenue forecast at $5,321,239.

If you're new to stock investing, here's how to buy Organovo Holdings stock.

What is ONVO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ONVO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 5.95%.

What is ONVO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ONVO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.